Cargando…

Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients

Background: Uremic toxins are associated with immune dysfunction and inflammation. The inadequate removal by hemodialysis (HD) of serum free light chains (FLCs) determines their accumulation. This study evaluated FLCs in HD patients, analyzing their relations with other biomarkers, such as serum hig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lacquaniti, Antonio, Campo, Susanna, Falliti, Giuseppe, Caruso, Daniele, Gargano, Romana, Giunta, Elena, Monardo, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739300/ https://www.ncbi.nlm.nih.gov/pubmed/36498479 http://dx.doi.org/10.3390/jcm11236904

Ejemplares similares

The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis
por: Lacquaniti, Antonio, et al.
Publicado: (2023)

Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same Coin
por: Campo, Susanna, et al.
Publicado: (2022)

Febrile Urinary Tract Infections in Children: The Role of High Mobility Group Box-1
por: Chimenz, Roberto, et al.
Publicado: (2022)

Acute Kidney Injury and Sepsis after Cardiac Surgery: The Roles of Tissue Inhibitor Metalloproteinase-2, Insulin-like Growth Factor Binding Protein-7, and Mid-Regional Pro-Adrenomedullin
por: Lacquaniti, Antonio, et al.
Publicado: (2023)

Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: reduction of erythropoietin dose in 4 years of follow-up
por: Lacquaniti, Antonio, et al.
Publicado: (2020)

Clinical Management of Hemodialyzed Patients: From Pharmacological Interventions to Advanced Technologies
por: Monardo, Paolo, et al.
Publicado: (2022)

Acute Kidney Injury: Advances in Clinical Management
por: Lacquaniti, Antonio, et al.
Publicado: (2022)

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
por: Savica, Vincenzo, et al.
Publicado: (2008)

Aberrant Expression of High Mobility Group Box Protein 1 in the Idiopathic Inflammatory Myopathies
por: Day, Jessica, et al.
Publicado: (2020)

High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

High mobility group box 1 in diabetic nephropathy
por: Shi, Haitao, et al.
Publicado: (2017)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

Sample Preparation Strategies for Antibody-Free Quantitative Analysis of High Mobility Group Box 1 Protein
por: Kvivik, Ingeborg, et al.
Publicado: (2021)

Serum level of high mobility group box protein-1 and prognosis of patients with end-stage renal disease on hemodialysis and peritoneal dialysis
por: Chen, Linyan, et al.
Publicado: (2021)

High mobility group box 1: as a 'testament' mediator
por: Maruyama, I, et al.
Publicado: (2005)

The Role of High Mobility Group Box 1 in Innate Immunity
por: Lee, Shin-Ae, et al.
Publicado: (2014)

High Mobility Group Box Protein-1 in Wound Repair
por: Ranzato, Elia, et al.
Publicado: (2012)

High-Mobility Group Box 1 in Dry Eye Inflammation
por: Lema, Carolina, et al.
Publicado: (2018)

The Role of High Mobility Group Box 1 in Ischemic Stroke
por: Ye, Yingze, et al.
Publicado: (2019)

Role of High-Mobility Group Box-1 in Liver Pathogenesis
por: Khambu, Bilon, et al.
Publicado: (2019)

High Mobility Group Box 1 Protein in Cerebral Thromboemboli
por: Essig, Fabian, et al.
Publicado: (2021)

Urinary and serum levels of high mobility group box 1
por: Nakamura, Toshihiko, et al.
Publicado: (2023)

Removal of free light chains in hemodialysis patients without multiple myeloma: a crossover comparison of three different dialyzers
por: Donati, Gabriele, et al.
Publicado: (2016)

Cell-Free DNA, High-Mobility Group Box-1, and Procalcitonin Concentrations in Dogs With Gastric Dilatation–Volvulus Syndrome
por: Troia, Roberta, et al.
Publicado: (2018)

Identification and Characterization of the Lamprey High-Mobility Group Box 1 Gene
por: Pang, Yue, et al.
Publicado: (2012)

Expression and Effects of High-Mobility Group Box 1 in Cervical Cancer
por: Pang, Xiaoao, et al.
Publicado: (2014)

High Mobility Group Box 1 Expression in Oral Inflammation and Regeneration
por: Yamashiro, Keisuke, et al.
Publicado: (2020)

High Mobility Group Box-1 and Blood–Brain Barrier Disruption
por: Nishibori, Masahiro, et al.
Publicado: (2020)

The Roles of High Mobility Group Box 1 in Cerebral Ischemic Injury
por: Gou, Xiaoyun, et al.
Publicado: (2020)

Role of Glycated High Mobility Group Box-1 in Gastric Cancer
por: Kishi, Shingo, et al.
Publicado: (2021)

Light chain myeloma and detection of free light chains in serum and urine of dogs and cats
por: Harris, Robert Adam, et al.
Publicado: (2021)

Multiple myeloma: Detection of free monoclonal light chains by modified immunofixation electrophoresis with antisera against free light chains
por: Wilhite, Dorian, et al.
Publicado: (2021)

Oxidation Stress as a Mechanism of Aging in Human Erythrocytes: Protective Effect of Quercetin
por: Remigante, Alessia, et al.
Publicado: (2022)

Aging Injury Impairs Structural Properties and Cell Signaling in Human Red Blood Cells; Açaì Berry Is a Keystone
por: Spinelli, Sara, et al.
Publicado: (2023)

High Mobility Group Box 1 Protein Induction by Mycobacterium Bovis BCG
por: Hofner, Péter, et al.
Publicado: (2007)

Bench-to-bedside review: High-mobility group box 1 and critical illness
por: Fink, Mitchell P
Publicado: (2007)

High mobility group box-1 protein – one step closer to the clinic?
por: Mollnes, Tom Eirik
Publicado: (2008)

Unraveling the role of high mobility group box protein 1 in severe trauma
por: Abraham, Edward
Publicado: (2009)

High mobility group box-1 recognition: The beginning of a RAGEless era?
por: Branco-Madeira, Filipe, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_4ckpmm4a6h0385rpbol2m98vsf